Experimental: Atorvastatin followed by misoprostol for Miscarriage

Phase-Based Progress Estimates
Planned Parenthood Association of Utah, Salt Lake City, UTMiscarriageAtorvastatin - Drug
18 - 50
What conditions do you have?

Study Summary

This trialis testing if a new type of pill can end a pregnancy. Participants take a pill at the clinic, and then take it daily for 6 more days, then return to the clinic and take another pill. Follow-up visits include an ultrasound to check if the abortion was successful.

Treatment Effectiveness

Effectiveness Progress

1 of 3

Study Objectives

1 Primary · 0 Secondary · Reporting Duration: Within 7 days of initiating atorvastatin (80 mg per day)

Day 7
Interference in pregnancy progress

Trial Safety

Safety Progress

1 of 3

Trial Design

1 Treatment Group

Experimental: Atorvastatin followed by misoprostol
1 of 1

Experimental Treatment

30 Total Participants · 1 Treatment Group

Primary Treatment: Experimental: Atorvastatin followed by misoprostol · No Placebo Group · Phase < 1

Experimental: Atorvastatin followed by misoprostolExperimental Group · 2 Interventions: Atorvastatin, Misoprostol · Intervention Types: Drug, Drug
First Studied
Drug Approval Stage
How many patients have taken this drug
Completed Phase 4
Completed Phase 4

Trial Logistics

Trial Timeline

Screening: ~3 weeks
Treatment: Varies
Reporting: within 7 days of initiating atorvastatin (80 mg per day)

Who is running the clinical trial?

University of UtahLead Sponsor
1,008 Previous Clinical Trials
1,787,352 Total Patients Enrolled
Grand Challenges CanadaOTHER
61 Previous Clinical Trials
95,317 Total Patients Enrolled
David Turok, MD, MPHPrincipal InvestigatorUniversity of Utah
3 Previous Clinical Trials
1,299 Total Patients Enrolled

Eligibility Criteria

Age 18 - 50 · Female Participants · 7 Total Inclusion Criteria

Mark “Yes” if the following statements are true for you:
You are trying to end a pregnancy.
You must be able to speak either English or Spanish.

Frequently Asked Questions

Is this experiment accommodating elderly individuals?

"Eligibility for this study necessitates that participants be aged 18 or older, and under 50 years of age." - Anonymous Online Contributor

Unverified Answer

Is the recruitment for this clinical experiment still open?

"Per the details on clinicaltrials.gov, this research is currently enrolling participants. It was initially posted in April of 2022 and its data was most recently updated at the end of October that same year." - Anonymous Online Contributor

Unverified Answer

What type of participants are most suitable for this research?

"This clinical trial seeks 30 individuals aged between 18 and 50 who have experienced an early abortion. The prospective participants must be able to speak English or Spanish, willing to postpone their termination of pregnancy by up to two weeks, abstain from contraception until the completion of their abortion procedure, comply with all protocol requirements, and accept that they may require a uterine aspiration in order for the study regimen to successfully terminate their pregnancy." - Anonymous Online Contributor

Unverified Answer

How many participants are currently included in this research endeavor?

"Affirmative, clinicaltrials.gov verifies that this trial is currently seeking participants. The study was first published on April 19th 2022 and has recently been edited on October 28th 2022. 30 individuals are required from 1 medical centre for the experiment to commence." - Anonymous Online Contributor

Unverified Answer
Please Note: These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.